MedMira Inc
XTSX:MIR

Watchlist Manager
MedMira Inc Logo
MedMira Inc
XTSX:MIR
Watchlist
Price: 0.095 CAD 11.76% Market Closed
Market Cap: 72m CAD
Have any thoughts about
MedMira Inc?
Write Note

Net Margin
MedMira Inc

-806.2%
Current
-422%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-806.2%
=
Net Income
-3.3m
/
Revenue
412.6k

Net Margin Across Competitors

Country CA
Market Cap 59.6m CAD
Net Margin
-806%
Country US
Market Cap 199.4B USD
Net Margin
14%
Country US
Market Cap 190.4B USD
Net Margin
29%
Country US
Market Cap 139.9B USD
Net Margin
16%
Country US
Market Cap 133.6B USD
Net Margin
11%
Country IE
Market Cap 103.6B USD
Net Margin
13%
Country US
Market Cap 66B USD
Net Margin
9%
Country DE
Market Cap 58.2B EUR
Net Margin
8%
Country US
Market Cap 44.6B USD
Net Margin
74%
Country CN
Market Cap 313.1B CNY
Net Margin
33%
Country US
Market Cap 36.2B USD
Net Margin
9%
No Stocks Found

MedMira Inc
Glance View

Market Cap
66.7m CAD
Industry
Health Care

MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four test results using one test cartridge and one drop of specimen. The company also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The firm sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others.

MIR Intrinsic Value
0.002 CAD
Overvaluation 98%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-806.2%
=
Net Income
-3.3m
/
Revenue
412.6k
What is the Net Margin of MedMira Inc?

Based on MedMira Inc's most recent financial statements, the company has Net Margin of -806.2%.